The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PTGX FINANCIAL STATEMENTS

Protagonist Therapeutics Inc — balance sheet, income statement and cash flow trends

PTGXProtagonist Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0200 M400 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue282 M $Gross Profit281.6 M $ · 100%Operating Income58.3 M $ · 21%Pre-tax Income84.3 M $ · 30%Net Income to Owners82.9 M $ · 29%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue282 M $+34.8%
Gross Profit281.6 M $+34.6%
Operating Income58.3 M $+143.3%
EBITDA85.5 M $+54.0%
Net Income to Owners82.9 M $+59.3%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets885.5 M
  • Equity841.5 M $95%
  • Current Liabilities37.2 M $4%
  • Long-term Liabilities6.8 M $1%

Key Figures

YoY change
Total Assets885.5 M $+23.3%
Total Liabilities44 M $-12.0%
Total Equity841.5 M $+26.0%
Cash & ST Investments782.6 M $+37.2%
Total Debt9.2 M $-18.3%
Net Debt-410.9 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0200 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0100 M200 M131.2 M $Operating78.7 M $Investing41.6 M $Financing251.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow131.2 M $+231.8%
Capital Expenditures1.9 M $-21.5%
Free Cash Flow132.2 M $+256.3%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PTGX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.